Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 2/20 | 0.71 |
| ▸ | NPC1 | O15118 | 9/20 | 0.58 |
| ▸ | RAB9A | P51151 | 9/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.58 |
| ▸ | RELA | Q04206 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | NOS2 | P35228 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30760998 | 1.00 | NCF1 (0.71) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL29833517 | 0.87 | NCF1 (0.61) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL396525 | 0.87 | NCF1 (0.61) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL2844247 | 0.86 | NPC1 (0.59) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL1702119 | 0.86 | NPC1 (0.59) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL1703679 | 0.84 | RAB9A (0.59) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL1702196 | 0.83 | NCF1 (0.57) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL9402367 | 0.83 | NCF1 (0.52) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL5806618 | 0.83 | NCF1 (0.68) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL5506476 | 0.83 | NCF1 (1.00) | NCF1NPC1RAB9AKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-56049320-A | — | — | None | — | — | JP | disclosed |
| US-12029055-B2 | OLED with hybrid emissive layer | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-02 | — | — | US | disclosed |
| US-11812624-B2 | Organic electroluminescent materials and devices | UNITED STATES DEPARTMENT OF ENERGY | 2023-11-07 | — | — | US | disclosed |
| US-11812624-B2 | Organic electroluminescent materials and devices | UNITED STATES DEPARTMENT OF ENERGY | 2023-11-07 | — | — | US | disclosed |
| US-11780829-B2 | Organic electroluminescent materials and devices | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-10-10 | — | — | US | disclosed |
| US-11780829-B2 | Organic electroluminescent materials and devices | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-10-10 | — | — | US | disclosed |
| EP-3690973-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | University Of Southern California (US) | 2020-08-05 | — | — | EP | disclosed |
| US-20200239456-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNITED STATES DEPARTMENT OF ENERGY | 2020-07-30 | — | — | US | disclosed |
| US-20200243772-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNITED STATES DEPARTMENT OF ENERGY | 2020-07-30 | — | — | US | disclosed |
| US-20190237694-A1 | OLED WITH HYBRID EMISSIVE LAYER | UNITED STATES DEPARTMENT OF ENERGY | 2019-08-01 | — | — | US | disclosed |
| US-9118024-B2 | Electroluminescent devices having a color emitting galium complex | ROYSTER TOMMIE (US) | 2015-08-25 | — | — | US | disclosed |
| US-9118024-B2 | Electroluminescent devices having a color emitting galium complex | ROYSTER TOMMIE (US) | 2015-08-25 | — | — | US | disclosed |
| US-8222634-B2 | Anthracene derivatives and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-07-17 | — | — | US | disclosed |
| US-8222634-B2 | Anthracene derivatives and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-07-17 | — | — | US | disclosed |
| US-20110024725-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-02-03 | — | — | US | disclosed |
| US-20110024725-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-02-03 | — | — | US | disclosed |
| WO-2008143440-A1 | NEW ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2008-11-27 | — | — | WO | disclosed |
| JP-S5649320-A | REMEDY FOR CARDIOVASCULAR DISEASE | MOCHIDA PHARMACEUT CO LTD | 1981-05-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11812624-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, HCRTR2 | NCF1 2856/4885NPC1 2977/4885RAB9A 2800/4885 |
| US-12029055-B2 | OLED with hybrid emissive layer | S1PR4, S1PR1, S1PR2 | NCF1 2338/4885NPC1 80/4885RAB9A 2619/4885 |
| US-20110024725-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | VDAC2, VDAC3, ANXA1 | NCF1 2773/4885NPC1 3958/4885RAB9A 3509/4885 |
| US-20200243772-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, HCRTR2 | NCF1 2856/4885NPC1 2977/4885RAB9A 2800/4885 |
| US-20190237694-A1 | OLED WITH HYBRID EMISSIVE LAYER | S1PR4, S1PR2, S1PR1 | NCF1 2811/4885NPC1 95/4885RAB9A 2556/4885 |
| US-20200239456-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, HCRTR2 | NCF1 3110/4885NPC1 3384/4885RAB9A 2729/4885 |
| US-11780829-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, HCRTR2 | NCF1 3110/4885NPC1 3384/4885RAB9A 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.